chr16-23467668-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_015044.4(GGA2):c.1764C>A(p.Phe588Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000199 in 1,605,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar.
Frequency
Consequence
NM_015044.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GGA2 | NM_015044.4 | c.1764C>A | p.Phe588Leu | missense_variant | 17/17 | ENST00000309859.8 | |
GGA2 | XM_047433801.1 | c.1734C>A | p.Phe578Leu | missense_variant | 18/18 | ||
GGA2 | XM_047433802.1 | c.1653C>A | p.Phe551Leu | missense_variant | 17/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GGA2 | ENST00000309859.8 | c.1764C>A | p.Phe588Leu | missense_variant | 17/17 | 1 | NM_015044.4 | P1 | |
GGA2 | ENST00000567468.5 | c.625-2270C>A | intron_variant | 2 | |||||
GGA2 | ENST00000568922.1 | n.730C>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000683 AC: 17AN: 248744Hom.: 0 AF XY: 0.0000669 AC XY: 9AN XY: 134604
GnomAD4 exome AF: 0.0000186 AC: 27AN: 1452832Hom.: 0 Cov.: 28 AF XY: 0.0000221 AC XY: 16AN XY: 723424
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.1764C>A (p.F588L) alteration is located in exon 17 (coding exon 17) of the GGA2 gene. This alteration results from a C to A substitution at nucleotide position 1764, causing the phenylalanine (F) at amino acid position 588 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at